Performance Food Group Free cash flow increased by 11.2% to $542.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 69.8%, from $319.30M to $542.30M. Over 2 years (FY 2023 to FY 2025), Free cash flow shows an upward trend with a 11.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$178.40M | $7.40M | $77.90M | $164.50M | $275.80M | $50.60M | $153.60M | $82.40M | $33.90M | $373.00M | $305.40M | $55.10M | -$43.00M | $218.10M | $319.30M | $209.70M | -$224.10M | $487.80M | $542.30M |
| QoQ Change | — | +104.1% | +952.7% | +111.2% | +67.7% | -81.7% | +203.6% | -46.4% | -58.9% | >999% | -18.1% | -82.0% | -178.0% | +607.2% | +46.4% | -34.3% | -206.9% | +317.7% | +11.2% |
| YoY Change | — | — | — | — | >999% | -35.0% | -6.6% | — | -87.7% | +637.2% | +98.8% | -33.1% | -226.8% | -41.5% | +4.6% | +280.6% | -421.2% | +123.7% | +69.8% |